Institutional investors purchased a net $2.4 million shares of OMER during the quarter ended September 2017, and now own 50.50% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SUSQUEHANNA FINANCIAL GROUP LLLP Bought 531.7 Thousand shares of Omeros Corp
ECOR1 CAPITAL LLC Bought 450.0 Thousand shares of Omeros Corp